Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Area of interest

Area of interest

Type

Type

Guidance programme

Advice programme

Showing 231 to 240 of 330

TitleReference numberPublishedLast updated
Pertuzumab for the neoadjuvant treatment of HER2-positive breast cancerTA424
Necitumumab for untreated advanced or metastatic squamous non-small-cell lung cancerTA411
Radium-223 dichloride for treating hormone-relapsed prostate cancer with bone metastasesTA412
Crizotinib for untreated anaplastic lymphoma kinase-positive advanced non-small-cell lung cancerTA406
Axxent electronic brachytherapy system for early stage breast cancerMIB76
OSNA for colon cancer stagingMIB77
Cabazitaxel for hormone-relapsed metastatic prostate cancer treated with docetaxelTA391
Trifluridine–tipiracil for previously treated metastatic colorectal cancerTA405
Pemetrexed maintenance treatment for non-squamous non-small-cell lung cancer after pemetrexed and cisplatinTA402
Ramucirumab for previously treated locally advanced or metastatic non-small-cell lung cancerTA403

Results per page

  1. 10
  2. 25
  3. 50
  4. All